  |
Neonatal Drug Therapy Manual |
Policies on Intravenous Solutions and Medications
TOH: Please refer to The Ottawa Hospital Nursing Policy, Procedure and Protocol Manual and The Otttawa Hospital Parenteral Drug Therapy Manual.
CHEO: Please refer to the appropriate Nursing Policy, Procedure and Protocol Manual and the CHEO Parenteral Drug Therapy Manual.
Latex Precautions and Intravenous Solutions/Medications
When latex precautions are ordered for a neonate with specific conditions (for example neural tube defect, bladder exstrophy), trace amount of latex found in medications and total parenteral nutrition will be accepted unless otherwise requested by the medical team.
Please be advised that the on-line CHEOnet version of this manual is the most up to date version. All directors responsible for the area need to ensure that the most up to date information is printed and placed in the manual.
The information contained on this website is provided for informational purposes only, as a guide to assist physicians, nurses and other healthcare providers in deciding on the appropriate care required for a particular patient. At all times, physicians, nurses and other healthcare providers must exercise their independent clinical judgment, based on their knowledge, training and experience, taking into account the specific facts and circumstances of each patient, when deciding on the appropriate course of investigation and/or treatment to recommend in a particular clinical situation.
CHEO has made every effort to ensure that the information contained on this website is as current and accurate as possible. However, changes can occur due to ongoing research and the constant influx of new information. Where possible, hospitals and healthcare practitioners should verify the information before acting on it.
Reliance on any information in this website is at the user's own risk. CHEO is not responsible or liable for any harm, loss or other consequences from the use or misuse of the information on this website.
